Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
Cancer Treatment Reviews · 2023-09 · 119 · 102586
DOI: 10.1016/j.ctrv.2023.102586 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Treatment Reviews, 2023-09. Verfasst von Carlotta Becherini und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology De…. Hauptthemen laut MEDLINE: Radiosurgery, Breast Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, UK.
- Department of Radiation Oncology, Hospital Sírio-Libanês, Sao Paulo, Brazil; Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
- Division of Medical and Radiation Oncology and Hematology, Skåne University Hospital, Lund, Sweden.
Zitieren
APA
Becherini, C., Visani, L., Caini, S., Bhattacharya, I. S., Kirby, A. M., Nader Marta, G., Morgan, G., Salvestrini, V., Coles, C. E., Cortes, J., Curigliano, G., de Azambuja, E., Harbeck, N., Isacke, C. M., Kaidar-Person, O., Marangoni, E., Offersen, B., Rugo, H. S., Morandi, A., …, & Meattini, I. (2023). Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis. Cancer Treatment Reviews, 119, 102586. https://doi.org/10.1016/j.ctrv.2023.102586
Vancouver
Becherini C, Visani L, Caini S, Bhattacharya IS, Kirby AM, Nader Marta G, et al. Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis. Cancer Treatment Reviews. 2023;119:102586. doi:10.1016/j.ctrv.2023.102586
BibTeX
@article{Becherini2023,
author = {Becherini, Carlotta and Visani, Luca and Caini, Saverio and Bhattacharya, Indrani S and Kirby, Anna M and Nader Marta, Gustavo and Morgan, Gilberto and Salvestrini, Viola and Coles, Charlotte E and Cortes, Javier and Curigliano, Giuseppe and de Azambuja, Evandro and Harbeck, Nadia and Isacke, Clare M and Kaidar-Person, Orit and Marangoni, Elisabetta and Offersen, Birgitte and Rugo, Hope S and Morandi, Andrea and Lambertini, Matteo and Poortmans, Philip and Livi, Lorenzo and Meattini, Icro},
title = {Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {119},
pages = {102586},
doi = {10.1016/j.ctrv.2023.102586}
}
EUVIMED